BMO Capital raised the firm’s price target on AMN Healthcare (AMN) to $25 from $22 and keeps an Outperform rating on the shares. The firm is adjusting its estimates after the management disclosed its updated expectations for 2026 and beyond at the JP Morgan Healthcare Conference, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMN: